Overview

• Spinncloud has clinched a million-euro-scale contract with the University of Leipzig to deploy its neuromorphic SpiNNaker2 system.
• The supercomputer will simulate over 10 billion artificial neurons simultaneously, equating to about 20 percent of human-brain performance.
• SpiNNaker2’s architecture cuts power consumption by roughly 18 times compared with standard high-performance computing setups.
• Initial model tests suggest the platform can accelerate small-molecule drug screening by up to 50 times versus conventional AI chips.
• The project underscores Europe’s drive for technological sovereignty by advancing homegrown AI hardware in drug discovery.